“…Of note, however, several hypotheses have been proposed regarding the mechanisms underlying the neurodegeneration in ALS. In particular, the excitotoxicity hypothesis, which proposes that neurodegeneration in ALS is associated with selective neuronal deaths that occur as a result of overstimulation of the glutamate receptors in the brain (Bakulin, Chervyakov, Suponeva, Zakharova, & Piradov, 2016;Van Den Bosch, Van Damme, Bogaert, & Robberecht, 2006), has promoted the development of riluzole, the only drug licensed for treating ALS. Unfortunately, riluzole could only prolong survival by 2-3 months and provide no cure for ALS (Bensimon, Lacomblez, Meininger, & Group, 1994;Miller, Mitchell, Lyon, & Moore, 2007).…”